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Background: Excess smooth muscle cell (PASMC) proliferation contributes to vascular obstruction in pulmonary arterial hypertension (PAH). We 
recently described a role for impaired mitochondrial fusion in this proliferative diasthesis due to decreased expression of mitofusin-2 (MFN2). We 
hypothesize that decreased expression of proliferator-activated receptor gamma coactivator gene (PGC1α) reduces MFN2 expression, resulting in 
impaired mitochondrial fusion and increased PASMC proliferation.
methods: Expression of PGC1α was performed in lungs and PASMC from PAH patients and chronic hypoxia+Sugen-5416 (CH+SU) rats. Small 
inhibitory RNA (siRNA) was used to downregulate PGC1α or MFN2.
results: PAH-PASMC were hyperproliferative with fragmented mitochondria and decreased expression of PGC1α and MFN2. SiPGC1α reduced 
MFN2 expression in PASMC. SiMFN2 reduced PGC1α expression (Fig 1A). SiPGC1α and siMFN2 caused mitochondrial fragmentation (Fig 1B). 
SiMFN2 increased PASMC proliferation. Augmenting MFN2 using a serotype-5, adenoviral vector (Ad-MFN2) increased expression of MFN2 and 
PGC1α in human and CH+SU PASMC (Fig 1C), increased fusion and decreased PASMC proliferation.
conclusions: PGC1α regulates MFN2 expression in PASMC. A reciprocal relationship exists between MFN2 and PGC1α. Decreased PGC1α and 
MFN2 in PAH and CH+SU PASMC contributes to mitochondrial fragmentation and PASMC hyperproliferation. Augmenting MFN2 or PGC1α may have 
potential as antiproliferative therapies in PAH.
